Submission of Standalone audited financial results for the year ended 31 March, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
KMS Medisurgi Ltd has submitted its audited standalone financial results for FY2026 with a qualified opinion from auditors H H Dedhia & Associates. The auditor raised two concerns: (1) Post-employment benefits accounting deviates from AS-15 as no actuarial valuation was obtained, making the liability quantum unascertainable; (2) Stock records for material items remain unreconciled with books of accounts, though closing stock of Rs. 253.80 lakhs was physically verified. Revenue declined to Rs. 1,220.85 lakhs from Rs. 1,393.86 lakhs (approx 12.4% fall), while net profit dropped to Rs. 24.55 lakhs from Rs. 43.98 lakhs (approx 44% decline). The audit qualification is repetitive in nature. Management states the impact cannot be quantified but believes inventory differences are immaterial.
The qualified opinion raises concerns about accounting integrity and internal controls, particularly around inventory management and employee benefit calculations. The significant decline in profitability and unresolved audit issues may negatively impact investor confidence.